Chidamide API is a selective histone deacetylase (HDAC) inhibitor used in the treatment of peripheral T-cell lymphoma and certain hematological malignancies. It works by inducing tumor cell apoptosis and inhibiting cancer cell growth through epigenetic regulation. Chidamide API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations.

Chidamide API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.